Profile data is unavailable for this security.
About the company
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
- Revenue in EUR (TTM)3.31bn
- Net income in EUR148.70m
- Incorporated1990
- Employees14.34k
- LocationSartorius AGOtto-Brenner-Str. 20GOETTINGEN 37079GermanyDEU
- Phone+49 5513080
- Fax+49 5 513083289
- Websitehttps://www.sartorius.com/
Holder | Shares | % Held |
---|---|---|
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024 | 2.58m | 6.90% |
Schroder Investment Management Ltd.as of 29 Feb 2024 | 1.47m | 3.93% |
Impax Asset Management Ltd.as of 28 Mar 2024 | 925.55k | 2.47% |
The Vanguard Group, Inc.as of 05 Apr 2024 | 876.84k | 2.34% |
Baillie Gifford & Co.as of 31 Mar 2024 | 659.08k | 1.76% |
Allianz Global Investors GmbHas of 31 Jan 2024 | 636.24k | 1.70% |
BlackRock Fund Advisorsas of 04 Apr 2024 | 511.91k | 1.37% |
Franklin Advisers, Inc.as of 04 Apr 2024 | 464.31k | 1.24% |
DWS Investment GmbHas of 30 Apr 2024 | 389.60k | 1.04% |
Union Investment Privatfonds GmbHas of 30 Sep 2023 | 327.62k | 0.88% |